Epidural sufentanil for postoperative pain relief

Area of Science:

• Anesthesiology
• Pharmacology
• Orthopedic Surgery

Background:

• Effective pain management is crucial in the early postoperative period following orthopedic surgery.
• Epidural analgesia is a common method for managing surgical pain.
• Sufentanil is a potent opioid analgesic with potential for epidural administration.

Purpose of the Study:

• To evaluate the analgesic efficacy and safety of epidurally administered sufentanil in patients undergoing lower extremity orthopedic surgery.
• To determine the optimal dosage of epidural sufentanil for early postoperative pain control.

Main Methods:

• An open pilot study involving four groups of five adult patients each.
• Patients received varying doses of epidural sufentanil (15, 30, 50, or 75 micrograms) post-orthopedic surgery.
• Pain relief, duration of action, onset of action, and side effects were assessed.

Main Results:

• Satisfactory pain relief was achieved with 50 and 75 microgram doses, with mean durations of 372 and 307 minutes, respectively.
• Higher doses (above 50 micrograms) did not significantly improve pain relief quality or duration.
• Sedation was consistently observed with effective analgesia; respiratory depression was not evident.

Conclusions:

• Epidural sufentanil at doses of 50 micrograms and above is effective for early postoperative pain management in lower extremity orthopedic surgery.
• While higher doses may offer faster onset, 50 micrograms appears sufficient for prolonged pain relief.
• Common side effects include sedation, itching, and urinary retention, necessitating careful patient monitoring.